Skip to main content
Caplight Logo









ANNA (Allied Network for Neurodevelopmental Advancement)

ANNA (Allied Network for Neurodevelopmental Advancement)

Private
Sudbury, MassachusettsHealthcare & Life Scienceshttps://annaautismcare.com/

Last Round

Seed

Nov 1, 2024

Total Funding Raised

$9.26M

Company Overview

ANNA (Allied Network for Neurodevelopmental Advancement) is a healthcare company that provides evidence-based, play-based autism therapy and diagnostic services for children using Naturalistic Developmental Behavioral Interventions (NDBIs).

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

autism therapyABA therapynaturalistic developmental behavioral interventionNDBIautism diagnostic evaluationneurodiversity-affirming careAI-native healthcareparent coachingAI agentclinical decision supportRAG pipelinepediatric autism carebehavioral healthhealthtechAI-first clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ANNA (Allied Network for Neurodevelopmental Advancement) Comparables

Compare ANNA (Allied Network for Neurodevelopmental Advancement) with similar companies based on industry and business-model similarity.

ANNA (Allied Network for Neurodevelopmental Advancement) comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elevated Kids
87%
In STEPPS
80%
InBloom Autism Services
78%

ANNA (Allied Network for Neurodevelopmental Advancement) Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2024

Key People

Founding team and executive leadership

Aimun Malik

Chief Executive Officer

Executive Team

ANNA (Allied Network for Neurodevelopmental Advancement) Investors

Notable investors and investment history

ANNA (Allied Network for Neurodevelopmental Advancement) investors
InvestorRounds
re.Mind CapitalSeed
Watershed VenturesSeed
Greymatter CapitalSeed
VirtueSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2025

    Grew 32% QoQ, from 19 to 25 employees.

  • Jun 2, 2025

    Grew 17% QoQ, from 18 to 21 employees.

ANNA (Allied Network for Neurodevelopmental Advancement) Filings

Explore SEC and related filing metadata, where available.

ANNA (Allied Network for Neurodevelopmental Advancement) filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ANNA (Allied Network for Neurodevelopmental Advancement)'s valuation, stock price, and market status.

Is ANNA (Allied Network for Neurodevelopmental Advancement) a public or private company?

ANNA (Allied Network for Neurodevelopmental Advancement) is a private company.

What is the current stock price of ANNA (Allied Network for Neurodevelopmental Advancement)?

ANNA (Allied Network for Neurodevelopmental Advancement) is a private company with no public stock price. Caplight tracks ANNA (Allied Network for Neurodevelopmental Advancement)'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is ANNA (Allied Network for Neurodevelopmental Advancement) worth (valuation)?

Valuation information for ANNA (Allied Network for Neurodevelopmental Advancement) is not publicly available.

Can I buy ANNA (Allied Network for Neurodevelopmental Advancement) stock?

ANNA (Allied Network for Neurodevelopmental Advancement) shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ANNA (Allied Network for Neurodevelopmental Advancement)'s last funding round?

ANNA (Allied Network for Neurodevelopmental Advancement)'s most recent funding round was Seed on November 1, 2024.

Who are the main investors in ANNA (Allied Network for Neurodevelopmental Advancement)?

Key investors in ANNA (Allied Network for Neurodevelopmental Advancement) include re.Mind Capital, Watershed Ventures, Greymatter Capital, Virtue.

Will ANNA (Allied Network for Neurodevelopmental Advancement) IPO soon?

No public IPO plans have been announced for ANNA (Allied Network for Neurodevelopmental Advancement).

How can I track ANNA (Allied Network for Neurodevelopmental Advancement) secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ANNA (Allied Network for Neurodevelopmental Advancement)'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSudbury, Massachusetts
Employee Range24
Year Founded2023
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?